Literature DB >> 4653875

Haemostatic changes during dialysis associated with thrombus formation on dialysis membranes.

R M Lindsay, C R Prentice, J F Davidson, J A Burton, G P McNicol.   

Abstract

Platelet counts, coagulation factors, and the fibrinolytic system were studied in seven regular dialysis patients during the course of haemodialysis by parallel flow (Gambro-Alwall) and coil (Travenol Ultra-Flo 100) dialysers. Significant falls in the patients' platelet counts and rises in their factor V levels were found with both dialysis systems. The changes were more pronounced over the course of a Gambro-Alwall dialysis, when significant falls in the partial thromboplastin clotting time and in the plasminogen levels were also noted. These haemostatic changes were associated with the retention of platelets on the dialysis membranes and, in the case of the Gambro-Alwall dialyser, with the formation of platelet-fibrin thrombus. This thrombus formation may take place in spite of efficient heparin anticoagulation and may cause excessive blood loss to the regular dialysis patient.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4653875      PMCID: PMC1786749          DOI: 10.1136/bmj.4.5838.454

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  11 in total

1.  THE KAOLIN CLOTTING TIME OF PLATELET-RICH PLASMA: A TEST OF PLATELET FACTOR-3 AVAILABILITY.

Authors:  R M HARDISTY; R A HUTTON
Journal:  Br J Haematol       Date:  1965-05       Impact factor: 6.998

2.  The antiheparin effect of platelets.

Authors:  H C GODAL
Journal:  Scand J Clin Lab Invest       Date:  1962       Impact factor: 1.713

3.  Studies on the nature of the circulating anticoagulant directed against antihemophilic factor: with notes on an assay for anthemophilic factor.

Authors:  R T BRECKENRIDGE; C D RATNOFF
Journal:  Blood       Date:  1962-08       Impact factor: 22.113

4.  The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies.

Authors:  R R PROCTOR; S I RAPAPORT
Journal:  Am J Clin Pathol       Date:  1961-09       Impact factor: 2.493

5.  Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure.

Authors:  R D LANGDELL; R H WAGNER; K M BRINKHOUS
Journal:  J Lab Clin Med       Date:  1953-04

6.  Iatrogenic contribution to anaemia of chronic renal failure.

Authors:  A G Hocken; P K Marwah
Journal:  Lancet       Date:  1971-01-23       Impact factor: 79.321

7.  Summation: cellular reactions to the surface.

Authors:  E W Salzman
Journal:  Fed Proc       Date:  1971 Sep-Oct

8.  Hemodialysis and hemostatic function.

Authors:  V E Hesse; I B Mink; G P Murphy; R H Moore; J L Ambrus
Journal:  N Y State J Med       Date:  1970-07-15

9.  Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment.

Authors:  C Merskey; G J Kleiner; A J Johnson
Journal:  Blood       Date:  1966-07       Impact factor: 22.113

10.  The effect of chemical structure and surface properties of synthetic polymers on the coagulation of blood. II. Protein and platelet interaction with polymer surfaces.

Authors:  D J Lyman; J L Brash; S W Chaikin; K G Klein; M Carini
Journal:  Trans Am Soc Artif Intern Organs       Date:  1968
View more
  9 in total

1.  Ascites reinfusion using Rhodiascit apparatus--clinical experience and coagulation abnormalities.

Authors:  S P Wilkinson; A R Davidson; J Henderson; R Williams
Journal:  Postgrad Med J       Date:  1975-08       Impact factor: 2.401

2.  Experimental interactions of components of hemodialysis units with human blood.

Authors:  W H Zucker; B A Shinoda; R G Mason
Journal:  Am J Pathol       Date:  1974-04       Impact factor: 4.307

3.  Comparison of haemoperfusion and haemodialysis in the therapy of barbiturate intoxication in dogs.

Authors:  R K Medd; B Widdop; R A Braithwaite; A J Rees; R Goulding
Journal:  Arch Toxikol       Date:  1973

4.  [In vitro evaluation of adsorbents used in haemoperfusion (author's transl)].

Authors:  W R Külpmann; M Oellerich; U Blume; E Schmidt; M Barthels
Journal:  Klin Wochenschr       Date:  1978-12-01

Review 5.  Effect of heparin and heparin fractions on platelet aggregation.

Authors:  E W Salzman; R D Rosenberg; M H Smith; J N Lindon; L Favreau
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

6.  Salicylate removal by charcoal haemoperfusion in experimental intoxication in dogs:an assessment of efficacy and safety.

Authors:  C H Brookings; J D Ramsey
Journal:  Arch Toxicol       Date:  1975-11-20       Impact factor: 5.153

7.  Effect of heparin and prostacyclin-heparin infusion on blood coagulation in haemodialysed patients.

Authors:  M Kuźniewski; W Sułowicz; J Lisiewicz
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

8.  Influence of prostacyclin infusion on haemodialysis efficiency and blood cells.

Authors:  M Kuźniewski; W Sułowicz
Journal:  Int Urol Nephrol       Date:  1992       Impact factor: 2.370

9.  Use of a thromboxane synthetase inhibitor, dazoxiben, during haemodialysis.

Authors:  N J Dodd; M P Gordge; M J Weston
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.